TD Waterhouse Canada
TAK icon

TD Waterhouse Canada’s Takeda Pharmaceutical TAK Stock Holding History

TD Waterhouse Canada’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-125
Closed -$1.97K – 1805
2022
Q4 		$1.97K Hold
125
– – ﹤0.01% 1485
2022
Q3 		$1.63K Buy
+125
New +$1.74K ﹤0.01% 1523
2022
Q1 		– Sell
-185
Closed -$2.54K – 1867
2021
Q4 		$2.54K Buy
+185
New +$2.6K ﹤0.01% 1559

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

TD Waterhouse Canada's TAK Position: Q1 2023 in Review

TD Waterhouse Canada sold out of Takeda Pharmaceutical (TAK) in Q1 2023, closing a stake of 125 shares — an estimated $1.97K sold.

TD Waterhouse Canada first reported a position in TAK in Q4 2021 and held it in 3 quarters. The position peaked at $2.54K in Q4 2021. 300 funds tracked by Wall St. Rank hold TAK as of Q1 2023.

  • TD Waterhouse Canada reported no remaining Takeda Pharmaceutical position as of Q1 2023 after selling out during the quarter.
  • TD Waterhouse Canada sold 125 Takeda Pharmaceutical shares in Q1 2023, an estimated $1.97K.
  • TD Waterhouse Canada first reported a position in Takeda Pharmaceutical in Q4 2021 and held it in 3 quarters.
  • TD Waterhouse Canada's Takeda Pharmaceutical position peaked at $2.54K in Q4 2021.
  • 300 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2023.

Based on TD Waterhouse Canada's 13F filing for Q1 2023, filed 13 Nov 2023.